News

Technology News

Cynvenio Biosystems Launches Early Access Program

Friday, September 5, 2014 5:15:00 AM PDT | VentureDeal
   Los Angeles, California  --  Cynvenio Biosystems announced the launch of a new program that will grant early access to its proprietary isolation platform.

Cancer research labs will now have direct, on-site access to Cynvenio's genomic material for analysis with a variety of downstream molecular technologies.

Available through its LiquidBiopsy Rare Cell Isolation Platform, the system automates the identification and enrichment of rare tumor cells from patient blood draws.

The LiquidBiopsy method is complementary to standard tissue biopsies, according to the company.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1